血液系统用药
造血系统包括血液、骨髓、脾脏、淋巴结以及散布于全身各处的淋巴组织和单核-巨噬细胞组织。血液病，即所谓的造血系统疾病，主要表现为周围血细胞成分及功能的变化，以及出凝血机制障碍。尽管目前临床用于治疗血液病的药物种类较多，但大多数缺乏针对性，其疗效与实际需求仍存在一定差距。
| 中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
|---|---|---|---|---|
| 鲨肝醇 | batyl alcohol | 544-62-7 | C21H44O3 |
|
| 阿加曲班 | Argatroban monohydrate | 141396-28-3 | C23H36N6O5S*H2O |
|
| 阿加曲班 | argatroban | 74863-84-6 | C23H36N6O5S |
|
| 铁(2+)硫酸酯 | Iron(II) sulfate | 7782-63-0 (heptahydrate) | 2Fe*2O4S |
|
| 醋硝香豆素 | acenocoumarol | 152-72-7 | C19H15NO6 |
|
| 酚磺乙胺 | ethamsylate | 2624-44-4 | C4H11N*C6H6O5S |
|
| 达比加群酯 | dabigatran etexilate | 211915-06-9 | C34H41N7O5 |
|
| 达尔卓潘 | daltroban | 79094-20-5 | C16H16ClNO4S |
|
| 达唑氧苯 | dazoxiben | 78218-09-4 | C12H12N2O3 |
|
| 贝曲西班 | betrixaban | 330942-05-7 | C23H22ClN5O3 |
|
| 西洛他唑 | 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril | 73963-72-1 | C20H27N5O2 |
|
| 葡萄糖酸亚铁 | Iron(2+);2,3,4,5,6-pentahydroxyhexanoate | 299-29-6 | C12H22FeO14 |
|
| 葡聚糖 | Dextran | 9004-54-0 | C18H32O16 |
|
| 萘醌腙 | 1,2-naphthoquinone semicarbazone | 15687-37-3 | C11H9N3O2 |
|
| 茴香脑 | anethole | 104-46-1 | C10H12O |
|
| 苯茚二酮 | phenindione | 83-12-5 | C15H10O2 |
|
| 肾上腺酮 | adrenalone | 99-45-6 | C9H11NO3 |
|
| 肝素 | Lovenox | 9005-49-6 | C26H42N2O37S5 |
|
| 肝素 | Heparinsodiumsalt | 76149-63-8 | C12H21NO20S3 |
|
| 羟乙基淀粉 | (2S,3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol;2-[[(2R,3R,4S,5R,6S)-3,4,5,6-tetrakis(2-hydroxyethoxy)oxan-2-yl]methoxy]ethanol | 9005-27-0 | C22H44O17 |
|
| 美替诺龙醋酸酯 | 3-oxo-1-methyl-5α-androst-1-en-17β-yl acetate | 434-05-9 | C22H32O3 |
|
| 磷酸亚铁 | Phosphoric acid, iron(2+) salt (2:3), octahydrate | 10028-23-6 | Fe3H16O16P2 |
|
| 碳酸亚铁 | Carbonic acid;iron | 563-71-3 | CH2FeO3 |
|
| 硫酸氢氯吡格雷 | clopidogrel bisulfate | 135046-48-9 | C16H16ClNO2S*H2O4S |
|
| 硫酸亚铁 | Sulfuric acid, iron(2+), salt (1:1) | 10124-49-9 | FeH2O4S |
|
| 盐酸肾上腺酮 | 1-(3,4-dihydroxyphenyl)-1-oxo-2-methylamino-ethan-hydrochlorid | 62-13-5 | C9H11NO3*ClH |
|
| 盐酸沙格雷酯 | sarpogrelate hydrochloride | 135159-51-2 | C24H31NO6*ClH |
|
| 盐酸小檗胺 | berbamine hydrochloride | 6078-17-7 | C37H40N2O6*ClH |
|
| 盐酸噻氯匹定 | ticlopidine hydrochloride | 53885-35-1 | C14H14ClNS*ClH |
|
| 盐酸司维拉姆 | 2-(Chloromethyl)oxirane; hydron; 2-propen-1-amine; chloride | 152751-57-0 | C6H13Cl2NO |
|
| 甲磺酸达比加群酯 | dabigatran etexilate mesylate | 872728-81-9 | CH4O3S*C34H41N7O5 |
|
| 甘油磷酸铁 | Ferric 1-glycerophosphate | 1301-70-8 | C9H21Fe2O18P3 |
|
| 环丙基2-氟苯基二甲酮 | 1-cyclopropyl-2-(2-fluorophenyl)-1,2-ethanedione | 1391054-37-7 | C11H9FO2 |
|
| 海藻酸钙 | calcium;(2S,3S,4S,5S,6R)-6-[(2R,3S,4R,5S,6R)-2-carboxy-6-[(2R,3S,4R,5S,6R)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate | 9005-35-0 | C18H24CaO19 |
|
| 氯喳味唑酮 | anagrelide | 68475-42-3 | C10H7Cl2N3O |
|
| 氯吡格雷 | (S)-(+)-clopidogrel | 113665-84-2 | C16H16ClNO2S |
|
| 氯化钴 | cobalt(II) chloride | 7646-79-9 | Cl2Co |
|
| 氯克罗孟 | [8-Chloro-3-(2-diethylamino-ethyl)-4-methyl-2-oxo-2H-chromen-7-yloxy]-acetic acid ethyl ester | 68206-94-0 | C20H26ClNO5 |
|
| 替格瑞洛 | ticagrelor | 274693-27-5 | C23H28F2N6O4S |
|
| 普拉格雷 | prasugel | 150322-43-3 | C20H20FNO3S |
|
| 德尼布林 | N-[6-[[4-[[(2S)-2-amino-1-oxopropyl]amino]phenyl]thio]-1H-benzimidazol-2-yl]carbamic acid methyl ester | 284019-34-7 | C18H19N5O3S |
|
| 山梨醇铁 | Jectofer | 62765-90-6 | C12H19FeO13 |
|
| 小檗胺 | berbamine | 478-61-5 | C37H40N2O6 |
|
| 富马酸亚铁 | Eisenfumarat | 141-01-5 | C4H4FeO4 |
|
| 奥扎格雷 | ozagrel | 82571-53-7 | C13H12N2O2 |
|
| 地拉罗司 | deferasirox | 201530-41-8 | C21H15N3O4 |
|
| 噻氯匹定 | ticlopidine | 55142-85-3 | C14H14ClNS |
|
| 吲哚布芬 | indobufen | 63610-08-2 | C18H17NO3 |
|
| 双香豆素 | dicoumarol | 66-76-2 | C19H12O6 |
|
| 双香豆乙酯 | ethyl biscoumacetate | 548-00-5 | C22H16O8 |
|
- 1
- 2
- 1-2
联系我们
关注我们
公众号
